prof. Mgr. Vítězslav Bryja, Ph.D.
Department head, Department of Experimental Biology
correspondence Address:
Kotlářská 267/2, 611 37 Brno
office: bldg. D36/112
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 3291 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 218
2016
-
Analýza exprese ROR1 proteinu u pacientů s chronickou lymfocytární leukémií
Year: 2016, type: Conference abstract
-
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
Clinical cancer research, year: 2016, volume: 22, edition: 2, DOI
-
Automatic Detection and Segmentation of Exosomes in Transmission Electron Microscopy
Computer Vision -- ECCV 2016 Workshops: Amsterdam, The Netherlands, October 8-10 and 15-16, 2016, Proceedings, Part I, year: 2016
-
CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Publisher: Canadian Intellectual Property Office, state: Canada, patent's number: CA 2876908, year: 2016
-
CASEIN KINASE 1 INHIBITORS FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
Publisher: European patent Office, state: Germany, patent's number: EP2882437 (B1), year: 2016
-
Decreased expression of WNT3, a canonical Wnt pathway ligand is frequent in chronic lymphocytic leukemia progression and identifies patients with short treatment-free survival in mutated IGHV
Year: 2016, type: Conference abstract
-
Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV
British journal of haematology, year: 2016, volume: 175, edition: 5, DOI
-
Dishevelled is a NEK2 kinase substrate controlling dynamics of centrosomal linker proteins
Proceedings of the National Academy of Sciences of the United States of America, year: 2016, volume: 113, edition: 33, DOI
-
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells
Oncotarget, year: 2016, volume: 7, edition: 38, DOI
-
ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells
British Journal of Haematology, year: 2016, volume: 175, edition: 2, DOI